全球大腸直腸癌診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計大腸直腸癌診斷市場將從 2025 年的 201.4 億美元成長到 2034 年的 359.8 億美元，2026 年至 2034 年的複合年成長率為 6.66%。

由於全球大腸直腸癌發生率不斷上升，全球大腸癌診斷市場正在擴張。人口老化、久坐的生活方式和飲食習慣的改變顯著增加了大腸癌的發病率，導致對早期檢測和篩檢解決方案的需求日益成長。政府推行的定期體檢和健康宣傳活動也促進了市場成長。

分子診斷、生物標記檢測以及糞便大便潛血試驗等非侵入性篩檢方法的技術進步正在改變診斷格局。更高的準確性、更快的檢測結果報告以及微創操作提高了患者的依從性。此外，人工智慧在影像學和病理診斷中的應用也提高了檢出率並減少了診斷錯誤。

受精準醫療和個人化治療方案日益普及的推動，市場前景依然強勁。開發中國家醫療基礎設施的擴張和研發投入的增加將進一步加速市場成長。家用篩檢盒和數位健康平台的普及也有望提高醫療服務的可近性，並改善早期診斷效果。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球大腸直腸癌診斷市場：依檢測類型分類

• 市場分析、洞察與預測
• 驗血
• 糞便檢驗
• 影像檢查（CT、超音波、MRI、PET）
• 切片檢查
• 其他測試方法

第5章：全球大腸直腸癌診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷影像中心
• 癌症研究中心
• 其他最終用途

第6章 全球大腸直腸癌診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Danaher Corporation
  • DiaCarta
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche
  • GE HealthCare Technologies
  • Geneoscopy
  • Guardant Health
  • HU Group Holdings
  • New Day Diagnostics
  • Olympus Corporation
  • Phase Scientific International
  • QIAGEN NV
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

The Colorectal Cancer Diagnostics Market size is expected to reach USD 35.98 Billion in 2034 from USD 20.14 Billion (2025) growing at a CAGR of 6.66% during 2026-2034.

The global colorectal cancer diagnostics market is expanding due to the rising prevalence of colorectal cancer worldwide. Aging populations, sedentary lifestyles, and dietary changes have significantly increased the incidence rate, driving demand for early detection and screening solutions. Government initiatives promoting regular screenings and awareness campaigns are also contributing to market growth.

Technological advancements in molecular diagnostics, biomarker-based testing, and non-invasive screening methods such as fecal immunochemical tests are transforming the diagnostic landscape. Improved accuracy, faster turnaround times, and minimally invasive procedures are enhancing patient compliance. Additionally, integration of artificial intelligence in imaging and pathology is improving detection rates and reducing diagnostic errors.

Future prospects remain strong as precision medicine and personalized treatment approaches gain traction. Expansion of healthcare infrastructure in developing countries and growing investments in research and development will further accelerate market growth. Increasing adoption of home-based screening kits and digital health platforms is also expected to expand access and improve early diagnosis outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Blood Tests
• Stool Tests
• Imaging Tests (CT, Ultrasound, MRI, PET)
• Biopsy
• Other Test Types

By End Use

• Hospitals
• Diagnostic Imaging Centers
• Cancer Research Centers
• Other End Use

COMPANIES PROFILED

• Danaher Corporation, DiaCarta, Exact Sciences Corporation, F HoffmannLa Roche, GE HealthCare Technologies, Geneoscopy, Guardant Health, HU Group Holdings, New Day Diagnostics, Olympus Corporation, Phase Scientific International, QIAGEN NV, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Blood Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stool Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Imaging Tests (CT, Ultrasound, MRI, PET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cancer Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL COLORECTAL CANCER DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Danaher Corporation
  • 8.2.2 DiaCarta
  • 8.2.3 Exact Sciences Corporation
  • 8.2.4 F. Hoffmann-La Roche
  • 8.2.5 GE HealthCare Technologies
  • 8.2.6 Geneoscopy
  • 8.2.7 Guardant Health
  • 8.2.8 H.U. Group Holdings
  • 8.2.9 New Day Diagnostics
  • 8.2.10 Olympus Corporation
  • 8.2.11 Phase Scientific International
  • 8.2.12 QIAGEN N.V
  • 8.2.13 Siemens Healthineers
  • 8.2.14 Sysmex Corporation
  • 8.2.15 Thermo Fisher Scientific